BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/27/2025 3:43:59 AM | Browse: 175 | Download: 400
 |
Received |
|
2025-05-06 02:56 |
|
Peer-Review Started |
|
2025-05-06 02:56 |
|
First Decision by Editorial Office Director |
|
2025-06-04 02:23 |
|
Return for Revision |
|
2025-06-04 02:23 |
|
Revised |
|
2025-06-04 14:38 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2025-07-30 02:38 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2025-07-30 05:09 |
|
Articles in Press |
|
2025-07-30 05:09 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-08-05 08:52 |
|
Publish the Manuscript Online |
|
2025-08-27 03:43 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Khaled Mohamed Mohamed Koriem |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Khaled Mohamed Mohamed Koriem, PhD, Professor, Department of Medical Physiology, Medical Research and Clinical Studies Institute, National Research Centre, 33 El-Buhouth Street, Dokki, P.O. Box, Giza 12622, Egypt. kkoriem@yahoo.com |
| Key Words |
Non-alcoholic fatty liver disease; Duodenal mucosal ablation; Irreversible electroporation; Lipid deposition; Endocrine function; Inflammatory markers |
| Core Tip |
The novel work by Yu et al on the feasibility and efficacy of duodenal mucosal ablation (DMA) with irreversible electroporation (IRE) in non-alcoholic fatty liver disease (NAFLD) rodents is thoroughly examined in this article. The duodenum repaired effectively two weeks after DMA with IRE, according to the study in a sophisticated manner. In NAFLD small rats, the detection of liver lipid deposition, serum lipid parameters, and enteroendocrine parameters such claudin and zonula ocludens-1 levels offer new opportunities for side-effects assessment and advanced therapy approaches. |
| Publish Date |
2025-08-27 03:43 |
| Citation |
Koriem KMM. Duodenal mucosal ablation with irreversible electroporation in non-alcoholic fatty liver disease: Roadmap of the future treatment. World J Gastroenterol 2025; 31(32): 109235 |
| URL |
https://www.wjgnet.com/1007-9327/full/v31/i32/109235.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v31.i32.109235 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
